Zobrazeno 101 - 110
of 303
pro vyhledávání: '"Benoit You"'
Autor:
Kaneko, Yutaro, Hatano, Ryo, Hirota, Naoto, Isambert, Nicolas, Trillet-Lenoir, Véronique, Benoit You, Alexandre, Jérôme, Zalcman, Gérard, Valleix, Fanny, Podoll, Thomas, Umezawa, Yoshimi, Takao, Seiichi, Iwata, Satoshi, Hosono, Osamu, Taguchi, Tetsuo, Taketo Yamada, Dang, Nam H., Ohnuma, Kei, Angevin, Eric, Morimoto, Chikao
Additional file 4: Table S3. Correlation between serum sCD26/DPP4 titer variation (%) and tumor volume change (%) or PFS (days) in 18 cases with Q2W administration by PPMC or SRDC analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c85a38f0477d96d828edfd13f342b6
Autor:
Karen A. Gelmon, Peter A. Fasching, Fergus J. Couch, Judith Balmaña, Suzette Delaloge, Intidhar Labidi-Galy, James Bennett, Susan McCutcheon, Graham Walker, Joyce O'Shaughnessy, Constanta Timcheva, Antoaneta Tomova, Andrea Eisen, Karen Gelmon, Julie Lemieux, Fernando Bazan, Hugues Bourgeois, Camille Chakiba, Mohamad Chehimi, Florence Dalenc, Thibault De La Motte Rouge, Jean-Sébastien Frenel, Anthony Gonçalves, Anne Claire Hardy-Bessard, Regine Lamy, Christelle Levy, Alain Lortholary, Audrey Mailliez, Jacques Medioni, Anne Patsouris, Dominique Spaeth, Luis Teixeira, Isabelle Tennevet, Cristian Villanueva, Benoit You, Johannes Ettl, Bernd Gerber, Oliver Hoffmann, Tjoung-Won Park-Simon, Mattea Reinisch, Joke Tio, Pauline Wimberger, Katalin Boer, Alberto Ballestrero, Giampaolo Bianchini, Laura Biganzoli, Roberto Bordonaro, Francesco Cognetti, Michelino De Laurentiis, Sabino De Placido, Valentina Guarneri, Filippo Montemurro, Giuseppe Naso, Armando Santoro, Claudio Zamagni, Seung-Jin Kim, Seigo Nakamura, Yee Soo Chae, Eun Kyung Cho, Kim Jee Hyun, Seock-Ah Im, Keun Seok Lee, Yeon Hee Park, Joo Hyuk Sohn, Tomasz Byrski, Tomasz Huzarski, Bozena Kukielka-Budny, Zbigniew Nowecki, Renata Szoszkiewicz, Rafal Tarnawski, Viktoria Dvornichenko, Fedor Moiseenko, Guzel Mukhametshina, Elena Poddubskaya, Ekaterina Popova, Anna Tarasova, Anna Vats, Bárbara Adamo, Raquel Andrés Conejero, Antonio Antón Torres, Judith Balmaña Gelpi, Nieves Díaz Fernández, Alejandro Falcón González, Juan Garcia, Isabel Lorenzo-Lorenzo, Fernando Moreno Antón, Marta Santisteban, Agostina Stradella, Chiun-Sheng Huang, Sercan Aksoy, Cagatay Arslan, Mehmet Artac, Adnan Aydiner, Ozgur Ozyilkan, Emel Sezer, Anne Armstrong, Sophie Barrett, Annabel Borley, Zoe Kemp, Caroline Michie, Mukesh Mukesh, Timothy Perren, Angela Swampillai, Tammy Young
Publikováno v:
European journal of cancer (Oxford, England : 1990). 152
Background In the phase III OlympiAD trial, olaparib significantly increased progression-free survival (PFS) compared with chemotherapy of physician's choice in patients with germline BRCA-mutated (gBRCAm), human epidermal growth factor 2 (HER2)-nega
Autor:
Fanny Valleix, Tetsuo Taguchi, Benoit You, Yutaro Kaneko, Thomas Podoll, Naoto Hirota, Nicolas Isambert, Kei Ohnuma, Ryo Hatano, Gérard Zalcman, Nam H. Dang, Eric Angevin, Véronique Trillet-Lenoir, Seiichi Takao, Yoshimi Umezawa, Taketo Yamada, Chikao Morimoto, Osamu Hosono, Satoshi Iwata, Jérôme Alexandre
Publikováno v:
Biomarker Research
Biomarker Research, Vol 9, Iss 1, Pp 1-13 (2021)
Biomarker Research, Vol 9, Iss 1, Pp 1-13 (2021)
Background The phase I trial of the humanized anti-CD26 monoclonal antibody YS110 for CD26-expressing tumors was conducted recently. The present study identifies a potential prognostic biomarker for CD26-targeted therapy based on the phase I data. Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36ce65814344ffa433e56209cace7b82
https://doi.org/10.21203/rs.3.rs-126614/v1
https://doi.org/10.21203/rs.3.rs-126614/v1
Autor:
M Puglisi, Nicoletta Colombo, Robert L. Coleman, Cagatay Taskiran, Ana Oaknin, Linda R. Duska, Kosei Hasegawa, M Raza Mirza, C Martin, David Cibula, Jacob Korach, Benoit You, Angélica Nogueira-Rodrigues, Y Xiang, Stephen Michael Keefe, Leslie M Randall, Jalid Sehouli, Melissa Christiaens, Sandro Pignata, Domenica Lorusso
Publikováno v:
Poster.
Background High-risk locally advanced cervical cancer (CC) has a poor prognosis, and >50% of patients recur in 2 years. Concurrent chemoradiotherapy (CRT) may enhance the immunostimulatory activity of the PD-1 inhibitor pembrolizumab. After KEYNOTE-1
Publikováno v:
Oral Poster – TAPED.
Introduction In VELIA (Phase 3), veliparib with carboplatin/paclitaxel (CP), followed by veliparib maintenance (veliparib-throughout) led to improved progression-free survival (PFS) vs CP alone (control). This exploratory analysis assessed the progno
Autor:
Frédéric Marchal, Catherine Arvieux, B. Paquette, Naoual Bakrin, Diane Goéré, Marc Pocard, Peggy Dartigues, Julio Abba, Charles Honoré, Denis Pezet, Olivia Sgarbura, R. Lo Dico, P. Rousset, Jérémie H. Lefevre, Maximiliano Gelli, Frédéric Guyon, Abdelkader Taibi, Clarisse Eveno, Sylvaine Durand-Fontanier, Benoit You, J. Fontaine, Olivier Bouché, Jean-Baptiste Delhorme, Olivier Glehen, Karine Abboud, C. Nadeau, Vahan Kepenekian, L. Gladieff, Jean-Jacques Tuech, Laurent Villeneuve
Publikováno v:
Journal of Visceral Surgery
Journal of Visceral Surgery, Elsevier, 2020, 157, pp.S25-S31. ⟨10.1016/j.jviscsurg.2020.04.013⟩
Journal of Visceral Surgery, Elsevier, 2020, 157, pp.S25-S31. ⟨10.1016/j.jviscsurg.2020.04.013⟩
The Covid-19 pandemic is profoundly changing the organization of healthcare access. This is particularly so for peritoneal neoplastic diseases, for which curative treatment mobilizes substantial personnel, operating room and intensive care resources.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e8dce6b533c0d60a23972e0b33518d
https://hal.archives-ouvertes.fr/hal-03491023
https://hal.archives-ouvertes.fr/hal-03491023
Autor:
P. Rousset, Jérémie H. Lefevre, Catherine Arvieux, Olivia Sgarbura, Marc Pocard, Sylvaine Durand-Fontanier, Olivier Bouché, Benoit You, Clarisse Eveno, Naoual Bakrin, Jean-Baptiste Delhorme, C. Nadeau, Diane Goéré, Laurent Villeneuve, Karine Abboud, Charles Honoré, Denis Pezet, Vahan Kepenekian, Abdelkader Taibi, R. Lo Dico, Frédéric Marchal, Peggy Dartigues, Frédéric Guyon, Julio Abba, Maximiliano Gelli, L. Gladieff, Jean-Jacques Tuech, Olivier Glehen, J. Fontaine, Brice Paquette
Publikováno v:
Journal de Chirurgie Viscérale
Resume La pandemie de COVID-19 modifie profondement l’organisation et l’acces aux soins, en particulier pour les pathologies neoplasiques peritoneales, dont la prise en charge curative mobilise des moyens importants en personnel, bloc operatoire
Autor:
Julien Péron, Michel Tod, Christophe Sajous, Adrian Cook, Gilles Freyer, Timothy J. Perren, Olivier Colomban, Alexandra Leary, Benoit You
Publikováno v:
JNCI Cancer Spectrum
Bevacizumab is approved as a maintenance treatment in first-line setting in advanced-stage III-IV ovarian cancers, because GOG-0218 and ICON-7 phase III trials demonstrated progression-free survival benefits. However, only the subgroup of patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23c797afc88f0ce5d9462aa2626a5708
Autor:
Thomas, Bachelot, Thomas, Filleron, Ivan, Bieche, Monica, Arnedos, Mario, Campone, Florence, Dalenc, Florence, Coussy, Marie-Paule, Sablin, Marc, Debled, Claudia, Lefeuvre-Plesse, Anthony, Goncalves, Marie-Ange Mouret, Reynier, William, Jacot, Benoit, You, Philippe, Barthelemy, Benjamin, Verret, Nicolas, Isambert, Xavier, Tchiknavorian, Christelle, Levy, Jean-Christophe, Thery, Tifenn, L'Haridon, Jean-Marc, Ferrero, Alice, Mege, Francesco, Del Piano, Etienne, Rouleau, Alicia, Tran-Dien, Julien, Adam, Amelie, Lusque, Marta, Jimenez, Alexandra, Jacquet, Ingrid, Garberis, Fabrice, Andre
Publikováno v:
Nature medicine. 27(2)
The impact of single-agent antibodies against programmed death-ligand 1 (PD-L1) as maintenance therapy is unknown in patients with metastatic breast cancer. The SAFIR02-BREAST IMMUNO substudy included patients with human epidermal growth factor recep
Autor:
Jérôme Meunier, Florence Joly, Joël Lachuer, E. Malaurie, Marie-Christine Kaminsky, Dominique Berton-Rigaud, Jérôme Alexandre, Gaëtan de Rauglaudre, Coraline Dubot, Michel Tod, Patrick Robelin, Olivier Colomban, Alexandra Leary, Gwenael Ferron, Isabelle Ray-Coquard, Alain Lortholary, Annick Chevalier-Place, Salima Hamizi, Benoit You, N. Raban, Pierre Combe
Publikováno v:
Gynecologic Oncology
Gynecologic Oncology, 2020, 159, pp.256-263. ⟨10.1016/j.ygyno.2020.07.021⟩
Gynecologic Oncology, Elsevier, 2020, 159, pp.256-263. ⟨10.1016/j.ygyno.2020.07.021⟩
Gynecologic Oncology, 2020, 159, pp.256-263. ⟨10.1016/j.ygyno.2020.07.021⟩
Gynecologic Oncology, Elsevier, 2020, 159, pp.256-263. ⟨10.1016/j.ygyno.2020.07.021⟩
International audience; Objective: MicroRNAs (miRNAs) are promising biomarkers in ovarian cancer. Their kinetics during treatment might be useful for monitoring disease burden, and guiding treatments in patients treated with peri-operative chemothera